Kumovis
Kumovis develops and manufactures 3D printers optimized for processing high-performance polymers for medical applications. The company's flagship product, the Kumovis R1 printer, is designed to produce patient-specific implants and surgical instruments from materials like PEEK, PEKK, and other medical-grade polymers. The printer features a clean room environment, precise temperature management, and a closed-loop quality monitoring system to meet the stringent requirements of the medical industry.
- CEO / Founder
- Miriam Haerst, Stefan Leonhardt (Co-CEOs at time of acquisition)
- Team Size
- 11-50
- Stage
- Acquired
- Total Funding
- Acquired
- Latest Round
- Acquired
Technology & Products
Key Products
["Kumovis R1 3D Printer (rebranded as EXT 220 MED by 3D Systems)"]
Technological Advantage
The company's technology enables decentralized manufacturing of medical devices, allowing hospitals and clinics to produce custom implants and instruments on-demand. This reduces lead times, lowers costs, and improves patient outcomes. The acquisition by 3D Systems provides Kumovis with access to a global distribution network and a broader portfolio of materials and technologies, further strengthening its market position.
Differentiation
Value Proposition
Kumovis provides a complete solution for medical 3D printing, enabling the production of high-quality, patient-specific medical products at the point of care. The company's technology allows for the use of high-performance polymers, which are ideal for demanding medical applications, and ensures a sterile and controlled manufacturing process.
How They Differentiate
As part of 3D Systems, Kumovis continues to differentiate through its specialized extrusion technology for medical-grade, high-performance polymers and integrated clean room solutions. Its unique capabilities enhance 3D Systems' comprehensive portfolio for patient-specific medical applications, offering a highly specialized and reliable 3D printing solution.
Market & Competition
Target Customers
Medical device manufacturers, hospitals, and research institutions.
Industry Verticals
["Medical","Healthcare"]
Competitors
As a 3D Systems company, Kumovis's competitors are now aligned with 3D Systems' broader additive manufacturing competitors in the medical sector, such as Stratasys and EOS.
Growth & Milestones
Growth Metrics
Acquired by 3D Systems in 2022.
Major Milestones
["2017: Company founded.","2018: Won the Munich Business Plan Competition.","2019: Launched the Kumovis R1 3D printer.","2020: Closed a €3.6 million Series A funding round.","2022: Acquired by 3D Systems."]
Notable Customers
Information not publicly available.